Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study-Reference-Cited by-同舟云学术

Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study

Published:2016-02-15 Issue:6 Volume:51 Page:799-806
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

van Gelder M,van Oers M H,Alemayehu W G,Abrahamse-Testroote M C J,Cornelissen J J,Chamuleau M E,Zachée P,Hoogendoorn M,Nijland M,Petersen E J,Beeker A,Timmers G-J,Verdonck L,Westerman M,de Weerdt O,Kater A P

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt20169.pdf

Reference50 articles.

1. Sorror ML, Storer BE, Sandmaier BM, Maris M, Shizuru J, Maziarz R et al. Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. J Clin Oncol 2008; 26: 4912–4920.

2. Dreger P, Schnaiter A, Zenz T, Bottcher S, Rossi M, Paschka P et al. TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial. Blood 2013; 121: 3284–3288.

3. Brown JR, Kim HT, Armand P, Cutler C, Fisher DC, Ho V et al. Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome. Leukemia 2013; 27: 362–369.

4. Khouri IF, Bassett R, Poindexter N, O'Brien S, Bueso-Ramos CE, Hsu Y et al. Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome. Cancer 2011; 117: 4679–4688.

5. Michallet M, Socie G, Mohty M, Sobh M, Bay JO, Morisset S et al. Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: long-term prospective multicenter study. Exp Hematol 2013; 41: 127–133.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review;Frontiers in Oncology;2023-01-18

2. Metformin dampens cisplatin cytotoxicity on leukemia cells after incorporation into cubosomal nanoformulation;Biomedicine & Pharmacotherapy;2021-11

3. Collaboration of Hprt/K-RAS/c-Myc mutation in the oncogenesis of T-lymphocytic leukemia: a comparative study;Future Science OA;2020-09-24

4. Chronic Lymphocytic Leukemia;The EBMT Handbook;2018-12-13

5. The latest developments with anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia;Expert Opinion on Biological Therapy;2018-08-10